Ardent Health, Inc. (NYSE:ARDT) Receives Consensus Recommendation of “Moderate Buy” from Analysts

Shares of Ardent Health, Inc. (NYSE:ARDT) have been assigned a consensus rating of “Moderate Buy” from the twelve research firms that are covering the stock, Marketbeat Ratings reports. Two equities research analysts have rated the stock with a sell recommendation, one has issued a hold recommendation and nine have issued a buy recommendation on the company. The average 1-year target price among analysts that have issued a report on the stock in the last year is $19.3273.

ARDT has been the topic of several analyst reports. JPMorgan Chase & Co. cut their price target on shares of Ardent Health from $18.00 to $15.00 and set a “neutral” rating on the stock in a report on Monday, August 11th. Bank of America lowered shares of Ardent Health from a “neutral” rating to an “underperform” rating and cut their price target for the stock from $15.50 to $14.60 in a report on Wednesday, July 16th. KeyCorp cut their price target on shares of Ardent Health from $24.00 to $20.00 and set an “overweight” rating on the stock in a report on Thursday, August 7th. UBS Group initiated coverage on shares of Ardent Health in a report on Wednesday, September 10th. They issued a “buy” rating and a $17.00 price target on the stock. Finally, Wall Street Zen raised shares of Ardent Health from a “buy” rating to a “strong-buy” rating in a report on Saturday, August 9th.

Ardent Health Stock Performance

Shares of NYSE:ARDT opened at $14.08 on Friday. The firm has a 50 day moving average of $12.91 and a 200 day moving average of $13.04. The company has a quick ratio of 2.00, a current ratio of 2.13 and a debt-to-equity ratio of 0.66. Ardent Health has a 52 week low of $10.10 and a 52 week high of $20.72. The company has a market capitalization of $2.01 billion, a price-to-earnings ratio of 7.78, a price-to-earnings-growth ratio of 6.34 and a beta of 0.39.

Ardent Health (NYSE:ARDT) last released its quarterly earnings results on Tuesday, August 5th. The company reported $0.52 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.30 by $0.22. Ardent Health had a net margin of 4.11% and a return on equity of 16.66%. The business had revenue of $1.65 billion for the quarter, compared to analyst estimates of $1.54 billion. Ardent Health has set its FY 2025 guidance at 1.730-2.01 EPS. On average, sell-side analysts predict that Ardent Health will post 1.23 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Ardent Health

A number of large investors have recently made changes to their positions in ARDT. Rhumbline Advisers grew its holdings in shares of Ardent Health by 46.8% during the first quarter. Rhumbline Advisers now owns 24,827 shares of the company’s stock valued at $341,000 after buying an additional 7,914 shares during the last quarter. Beacon Capital Management LLC purchased a new stake in shares of Ardent Health during the first quarter valued at $144,000. Allspring Global Investments Holdings LLC grew its holdings in shares of Ardent Health by 4.8% during the first quarter. Allspring Global Investments Holdings LLC now owns 817,182 shares of the company’s stock valued at $10,599,000 after buying an additional 37,581 shares during the last quarter. TBH Global Asset Management LLC purchased a new stake in shares of Ardent Health during the first quarter valued at $275,000. Finally, Bank of New York Mellon Corp grew its holdings in shares of Ardent Health by 91.2% during the first quarter. Bank of New York Mellon Corp now owns 48,988 shares of the company’s stock valued at $674,000 after buying an additional 23,373 shares during the last quarter.

About Ardent Health

Ardent Health Partners, Inc owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee.